Delivery Order SPE2DB20D3103-SPE2DB25FN5R2
Award Date
4/23/25
Potential Completion Date
5/14/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,862.79 fixed-price contract is for the supply of the prescription medication Zeposia 0.92 mg capsules. The contract has an ultimate completion date of May 20, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $13,399.71, is for the supply of Zeposia 0.92 mg capsules. Zeposia is a prescription medication used to treat certain medical conditions. The delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $4,466.57 firm-fixed-price contract is for the supply of the prescription medication Zeposia 0.92 MG Capsule 30S. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 MG capsules. The order, valued at $13,399.71, has a firm fixed price and a completion date of September 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering this medication to support various government healthcare programs and facilities, including military treatment facilities and veterans' hospitals. The contract is not set aside for any...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,862.79, is for the delivery of the medication ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a firm fixed price pricing type and a completion date of January 29, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order under contract SPE2DB24FJG97, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Zeposia 0.92 MG capsules, a specialty medication. The delivery order has a ceiling value of $26,799.42 and runs through August 9, 2024. AmerisourceBergen, a for-profit organization, was awarded this contract without any set-aside designation. This contract is part of a larger Indefinite...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,862.79, is for the delivery of Zeposia 0.92 mg capsules. It is a firm fixed-price Delivery Order contract with an ultimate completion date of April 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication, with a firm fixed price ceiling value of $13,862.79 and a period of performance through June 9, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of Zeposia 0.92 MG Capsules in 30-count packages, with a ceiling value of $13,399.71 and a completion date of July 5, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This federal contract award, valued at $13,862.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Zeposia 0.92 MG Capsule 30S, with a completion date of May 1, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...